Neoplasm of brain. Malignant neoplasm of brain(unspecified)
Conditions
Interventions
Intervention 1: Mannitol(20%):
Dose: 5 ml/kg
Number of using: Once
Factory name: Razi
Manufacturing Country's Name: Iran
Location prescribed: Intravenous Injection
Administration time: At the begi
Treatment - Drugs
Mannitol(20%):
Dose: 5 ml/kg
Number of using: Once
Factory name: Razi
Manufacturing Country's Name: Iran
Location prescribed: Intravenous Injection
Administration time: At the beginning of t
Hypertonic Saline(5%):
Dose: 2.5 ml/kg
Number of using: Once
Factory name: Alborz
Manufacturing Country's Name: Iran
Location prescribed: Intravenous Injection
Administration time: At the beg
Sponsors
Vice chancellor for research, Ahvaz Jundishapur University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: - The parent's consent - Age between 18 and 60 years old - ASA class I Exclusion criteria: - Previous complications with general anesthesia - Heart disease - Metabolic disorders - Chronic alcohol consumption - Brain herniation
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum Sodium. Timepoint: Before surgery, 120 minutes after the start of surgery and at the end of the surgery. Method of measurement: Laboratory.;Serum Pottasium. Timepoint: before surgery, 120 minutes after the start of surgery and at the end of the surgery. Method of measurement: Laboratory.;Serum Chlorine. Timepoint: Before surgery, 120 minutes after the start of surgery and at the end of the surgery. Method of measurement: Laboratory.;Bicarbonate. Timepoint: Before surgery, 120 minutes after the start of surgery and at the end of the surgery. Method of measurement: Laboratory. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHengameh Rajabzadeh
Ahvaz Jundishapur University of Medical Sciences
Outcome results
None listed